Dr. Robertson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
13330 Usf Laurel Dr
Tampa, FL 33612Phone+1 813-974-3541Fax+1 813-974-9145
Education & Training
- University of South Florida MorsaniResidency, Neurology, 2008 - 2012
- University of South Florida College of MedicineClass of 2008
Certifications & Licensure
- FL State Medical License 2012 - 2026
- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2013
Clinical Trials
- Adherence to Treatment With Tecfidera™ in Multiple Sclerosis Patients Start of enrollment: 2014 Mar 01
- A Study of Suboptimally Controlled Participants Previously Taking Oral or Infusion DMDs for RMS (MASTER-2) Start of enrollment: 2019 Jul 22
Roles: Principal Investigator
Publications & Presentations
PubMed
- Time-Dependent Deep Learning Prediction of Multiple Sclerosis Disability.John D Mayfield, Ryan Murtagh, John Ciotti, Derrick Robertson, Issam El Naqa
Journal of Imaging Informatics in Medicine. 2024-12-01 - Subcutaneous ocrelizumab in multiple sclerosis: Results of the Phase 1b OCARINA I study.Scott D Newsome, Lawrence Goldstick, Derrick S Robertson, James D Bowen, Robert T Naismith
Annals of Clinical and Translational Neurology. 2024-10-26 - 2 citationsUse of Calcitonin Gene-Related Peptide Monoclonal Antibodies for the Treatment of Migraines in Individuals With Multiple Sclerosis.Ashley Mason, Lauren Fragapane, Zuleyma Toledo-Nieves, Natalie Moreo, Angela Aungst
International Journal of MS Care. 2024-05-16
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: